• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活物是调节巨噬细胞三维侵袭、基质降解和黏附的核心调控因子。

Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.

机构信息

Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, Victoria 3050, Australia;

出版信息

J Immunol. 2014 Apr 15;192(8):3540-7. doi: 10.4049/jimmunol.1302864. Epub 2014 Mar 10.

DOI:10.4049/jimmunol.1302864
PMID:24616477
Abstract

Urokinase plasminogen activator (uPA) and its receptor (uPAR) coordinate a plasmin-mediated proteolytic cascade that has been implicated in cell adhesion, cell motility, and matrix breakdown, for example, during inflammation. As part of their function during inflammatory responses, macrophages move through tissues and encounter both two-dimensional (2D) surfaces and more complex three-dimensional (3D) interstitial matrices. Based on approaches employing uPA gene-deficient macrophages, plasminogen supplementation, and neutralization with specific protease inhibitors, it is reported in this study that uPA activity is a central component of the invasion of macrophages through a 3D Matrigel barrier; it also has a nonredundant role in macrophage-mediated matrix degradation. For murine macrophages, matrix metalloproteinase-9 activity was found to be required for these uPA-mediated effects. Evidence for a unique role for uPA in the inverse relationship between macrophage adhesion and 2D migration was also noted: macrophage adhesion to vitronectin was enhanced by uPA and blocked by plasminogen activator inhibitor-1, the latter approach also able to enhance in turn the 2D migration on this matrix protein. It is therefore proposed that uPA can have a key role in the inflammatory response at several levels as a central regulator of macrophage 3D invasion, matrix remodeling, and adhesion.

摘要

尿激酶型纤溶酶原激活物 (uPA) 及其受体 (uPAR) 协调纤溶酶介导的蛋白水解级联反应,该反应参与细胞黏附、细胞迁移和基质分解等过程,例如在炎症过程中。作为其在炎症反应过程中功能的一部分,巨噬细胞在组织中移动,同时遇到二维 (2D) 表面和更复杂的三维 (3D) 间质基质。本研究采用 uPA 基因缺陷型巨噬细胞、纤溶酶原补充以及特异性蛋白酶抑制剂中和等方法,报道 uPA 活性是巨噬细胞穿过 3D Matrigel 屏障侵袭的核心组成部分;它在巨噬细胞介导的基质降解中也具有非冗余作用。对于小鼠巨噬细胞,基质金属蛋白酶-9 活性被发现是这些 uPA 介导作用所必需的。还注意到 uPA 在巨噬细胞黏附和 2D 迁移之间的反比关系中具有独特作用的证据:uPA 增强了巨噬细胞对玻连蛋白的黏附,而纤溶酶原激活物抑制剂-1 则阻断了这种黏附,后者还能反过来增强在这种基质蛋白上的 2D 迁移。因此,uPA 可以作为巨噬细胞 3D 侵袭、基质重塑和黏附的中心调节剂,在几个层面上在炎症反应中发挥关键作用。

相似文献

1
Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.尿激酶型纤溶酶原激活物是调节巨噬细胞三维侵袭、基质降解和黏附的核心调控因子。
J Immunol. 2014 Apr 15;192(8):3540-7. doi: 10.4049/jimmunol.1302864. Epub 2014 Mar 10.
2
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].肿瘤细胞诱导的细胞外基质降解机制——抑制细胞表面蛋白水解活性可能对肿瘤细胞侵袭和转移具有治疗作用
Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32.
3
Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.巨噬细胞中尿激酶的过表达或1型纤溶酶原激活物抑制剂的缺乏会导致小鼠心脏纤维化。
Circ Res. 2004 Sep 17;95(6):637-44. doi: 10.1161/01.RES.0000141427.61023.f4. Epub 2004 Aug 5.
4
Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.尿激酶型纤溶酶原激活物受体促进巨噬细胞浸润到载脂蛋白E缺陷小鼠的血管壁中。
J Cell Physiol. 2005 Jul;204(1):73-82. doi: 10.1002/jcp.20262.
5
Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.转化生长因子-β1刺激巨噬细胞尿激酶表达并释放与基质结合的碱性成纤维细胞生长因子。
J Cell Physiol. 1993 Jun;155(3):595-605. doi: 10.1002/jcp.1041550317.
6
Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.尿激酶型纤溶酶原激活剂、其受体及纤溶酶原激活剂抑制剂-1在胃癌细胞中的表达及幽门螺杆菌的作用
Scand J Gastroenterol. 2005 Jul;40(7):783-93. doi: 10.1080/00365520510015665.
7
Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.纤溶酶原激活物和基质金属蛋白酶系统在表皮生长因子和分散因子刺激癌细胞侵袭中的作用。
Cancer Res. 1998 Nov 15;58(22):5221-30.
8
Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.肾细胞癌患者中尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体和纤溶酶原激活剂抑制剂的表达:与肿瘤相关巨噬细胞及预后的相关性
J Urol. 2005 Aug;174(2):461-5. doi: 10.1097/01.ju.0000165150.46006.92.
9
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.乳腺肿瘤组织基质中的尿激酶系统与乳腺癌细胞侵袭
Int J Oncol. 2009 Jan;34(1):15-23.
10
The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).一种人角质形成细胞系(HaCaT)的尿激酶型纤溶酶原激活剂受体。
Exp Cell Res. 1994 Oct;214(2):486-98. doi: 10.1006/excr.1994.1286.

引用本文的文献

1
Particle Shape Modulates the Function of Adoptive Macrophage Transfers.颗粒形状调节过继性巨噬细胞转移的功能。
Adv Healthc Mater. 2025 Aug 7:e01348. doi: 10.1002/adhm.202501348.
2
Immune cell-mediated venous thrombus resolution.免疫细胞介导的静脉血栓溶解。
Res Pract Thromb Haemost. 2023 Nov 20;7(8):102268. doi: 10.1016/j.rpth.2023.102268. eCollection 2023 Nov.
3
Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection.病毒抗炎丝氨酸蛋白酶抑制剂可降低 SARS-CoV-2 感染小鼠模型的免疫性凝血病理。
EMBO Mol Med. 2023 Sep 11;15(9):e17376. doi: 10.15252/emmm.202317376. Epub 2023 Aug 3.
4
Meningiomas with CNS invasion.伴有中枢神经系统侵犯的脑膜瘤。
Front Neurosci. 2023 Jun 29;17:1189606. doi: 10.3389/fnins.2023.1189606. eCollection 2023.
5
Meniscus repair via collagen matrix wrapping and bone marrow injection: clinical and biomolecular study.半月板修复通过胶原基质包裹和骨髓注射:临床和生物分子研究。
Int Orthop. 2023 Oct;47(10):2409-2417. doi: 10.1007/s00264-023-05711-2. Epub 2023 Feb 11.
6
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective.尿激酶型纤溶酶原激活物、尿激酶型纤溶酶原激活物受体及可溶性尿激酶型纤溶酶原激活物受体系统与类风湿关节炎炎症及关节损伤的关系:从个性化医疗角度看可溶性尿激酶型纤溶酶原激活物受体作为生物标志物
J Pers Med. 2022 Dec 1;12(12):1984. doi: 10.3390/jpm12121984.
7
Identifying crosstalk genetic biomarkers linking a neurodegenerative disease, Parkinson's disease, and periodontitis using integrated bioinformatics analyses.使用综合生物信息学分析识别连接神经退行性疾病、帕金森病和牙周炎的串扰遗传生物标志物。
Front Aging Neurosci. 2022 Dec 5;14:1032401. doi: 10.3389/fnagi.2022.1032401. eCollection 2022.
8
The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation.单核细胞中的组蛋白甲基转移酶 MLL1/KMT2A 驱动冠状病毒相关的凝血障碍和炎症。
Blood. 2023 Feb 16;141(7):725-742. doi: 10.1182/blood.2022015917.
9
Divergent regulation of basement membrane trafficking by human macrophages and cancer cells.人巨噬细胞和癌细胞对基底膜运输的差异调节。
Nat Commun. 2022 Oct 27;13(1):6409. doi: 10.1038/s41467-022-34087-x.
10
Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage.尿激酶型纤溶酶原激活剂在脑出血模型中增强脑源性神经营养因子的神经保护活性。
Biomedicines. 2022 Jun 8;10(6):1346. doi: 10.3390/biomedicines10061346.